News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Statement By Sanofi-Aventis (France) (SASY.PA)


10/19/2005 5:12:27 PM

PARIS, Jan. 19 /PRNewswire-FirstCall/ -- Rhodia announced today that it has commenced legal proceedings in the United States of America and Brazil against sanofi-aventis as former owner or operator of the Silver Bow (United States of America) and Cubatao (Brazil) sites to seek to obtain compensation for environmental liabilities related to these two sites.

Aventis and Rhodia signed a final settlement agreement on March 27, 2003 pursuant to which the two companies settled all claims in connection with the Environmental Indemnification Agreement signed by Aventis and Rhodia in 1998. Pursuant to this settlement agreement, which was publicly disclosed, Aventis made a final payment to Rhodia in 2004.

As a result of the settlement agreement, sanofi-aventis considers that the matter is closed and intends to vigorously defend its position in any legal proceedings.

About sanofi-aventis

Sanofi-aventis is the world's 3rd largest pharmaceutical company, ranking number 1 in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine, vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York .

CONTACT: Jean-Marc Podvin Vice President, Media Relations sanofi-aventis +331-53-77-4223 Charles F. Rouse III sanofi-aventis 908-243-6050

sanofi-aventis

CONTACT: Jean-Marc Podvin, Vice President, Media Relations,sanofi-aventis, +331-53-77-4223, or Charles F. Rouse III of sanofi-aventis,+1-908-243-6050


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES